Page last updated: 2024-11-04

sulfacetamide and Methemoglobinemia

sulfacetamide has been researched along with Methemoglobinemia in 1 studies

Sulfacetamide: An anti-bacterial agent that is used topically to treat skin infections and orally for urinary tract infections.
sulfacetamide : A sulfonamide that is sulfanilamide acylated on the sulfonamide nitrogen.

Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Güttner, J1

Other Studies

1 other study available for sulfacetamide and Methemoglobinemia

ArticleYear
[Supracid-induced methemoglobinemia with fatal outcome in a young infant].
    Padiatrie und Grenzgebiete, 1970, Volume: 9, Issue:1

    Topics: Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Medication Errors; Methemoglobinemia; Su

1970